Area of research
Molecular Biology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Extracellular vesicles in disease, Prostate Cancer Diagnosis and Treatment, Cancer Genomics and Diagnostics, and Prostate Cancer Treatment and Research.
A perspective from the National Eye Institute Extracellular Vesicle Workshop: Gaps, needs, and opportunities for studies of extracellular vesicles in vision research
The Liquid Biopsy Consortium: Challenges and opportunities for early cancer detection and monitoring
Extrinsic and intrinsic preanalytical variables affecting liquid biopsy in cancer
ExoDx prostate test as a predictor of outcomes of high-grade prostate cancer - an interim analysis.
Cerebrospinal fluid as a liquid biopsy for molecular characterization of brain metastasis in patients with non-small cell lung cancer
Cerebrospinal fluid as a liquid biopsy for molecular characterization of brain metastasis in patients with non-small cell lung cancer.
Longitudinal analysis of serum-derived extracellular vesicle RNA to monitor dacomitinib treatment response in EGFR-amplified recurrent glioblastoma patients.
Improved Sensitivity in BRAFV600E Detection in Combined Tissue and Extracellular Vesicle-Based Liquid Biopsy in Melanoma.
Predicting high-grade prostate cancer at initial biopsy: clinical performance of the ExoDx (EPI) Prostate Intelliscore test in three independent prospective studies.
Pre-diagnosis urine exosomal RNA (ExoDx EPI score) is associated with post-prostatectomy pathology outcome
Pre-diagnosis urine exosomal RNA (ExoDx EPI score) is associated with post-prostatectomy pathology outcome.
Validation of a CE-IVD, urine exosomal RNA expression assay for risk assessment of prostate cancer prior to biopsy.
Exosome based analysis for Space Associated Neuro-Ocular Syndrome and health risks in space exploration.
Exosome-based liquid biopsies in cancer: opportunities and challenges
Exosome-based liquid biopsies in cancer: opportunities and challenges.
Predicting high-grade prostate cancer at initial biopsy: clinical performance of the ExoDx (EPI) Prostate Intelliscore test in three independent prospective studies
Discovery and Validation of a Urinary Exosome mRNA Signature for the Diagnosis of Human Kidney Transplant Rejection.
A SARS-CoV-2 antigen rapid diagnostic test for resource limited settings.
Plasma Exosomal RNA Biomarkers of High-Risk Prostate Cancer.
OMRT-2. Liquid biopsy for patient stratification and monitoring of dacomitinib clinical trial in patients with EGFR amplified recurrent glioblastoma
2021cited by 0position: contributor
A SARS-CoV-2 Antigen Rapid Diagnostic Test for Resource Limited Settings
Plasmonic Sensors for Extracellular Vesicle Analysis: From Scientific Development to Translational Research
Clinical utility of the exosome based ExoDx Prostate(IntelliScore) EPI test in men presenting for initial Biopsy with a PSA 2-10 ng/mL.
A urine-based Exosomal gene expression test stratifies risk of high-grade prostate Cancer in men with prior negative prostate biopsy undergoing repeat biopsy.
Extracellular vesicles from plasma have higher tumour RNA fraction than platelets.
Exploring Predictors of Response to Dacomitinib in <i>EGFR</i>-Amplified Recurrent Glioblastoma.
Exosome/microvesicle content is altered in leucine-rich repeat kinase 2 mutant induced pluripotent stem cell-derived neural cells.
Clinical Performance of the ExoDx (EPI) Prostate Intelliscore Test to Predict High-grade Prostate Cancer at Initial Biopsy: A Pooled Analysis of Three Independent Prospective Studies.
A Urine-Based Exosomal Gene Expression Test Stratifies Risk of High-Grade Prostate Cancer in Men with Prior Negative Prostate Biopsy Undergoing Repeat Biopsy
Northeastern Section of the AUA 72nd Annual Meeting Abstracts
2020cited by 0position: contributor